Sources

14 Total Sources

FDA Approves Merck's $315 Lipfendra Pill, Cutting LDL Cholesterol by Up to 60%

Left69%

Center15%

Right15%

Scientific American7d ago

FDA Approves Enlicitide (Lipfendra), New Cholesterol Pill More Powerful Than Statins

The New York Times7d ago

FDA Approves Merck's New Pill Enlicitide (Lipfendra) for Significant Cholesterol Reduction

The New York Times7d ago

FDA Approves Merck's Enlicitide Pill to Significantly Lower Cholesterol

U.S. FDA Approves Merck's Lipfendra, First Oral PCSK9 Inhibitor Cholesterol Pill

FDA Approves New Pill-Form Drug Lipfendra to Halve LDL Cholesterol

The Washington Post7d ago

FDA Approves Merck's Lipfendra, a New Daily Cholesterol Pill

The Associated Press7d ago

FDA approves Merck's Lipfendra, a first-of-its-kind pill for high-risk cholesterol

FDA Approves Merck's Oral PCSK9 Inhibitor Lipfendra for High Cholesterol

Merck's cholesterol pill gets US FDA approval | Reuters

FDA Approves Merck's Daily PCSK9 Inhibitor Pill, Lipfendra, for High Cholesterol

FDA Approves Merck's Lipfendra, First Daily Oral Pill for LDL Cholesterol Reduction

abcnews.com7d ago

FDA Approves Merck's Oral Pill Lipfendra for LDL Cholesterol Reduction

Boston Herald8d ago

FDA Approves Merck's Lipfendra, First Noninjectable Pill for High Cholesterol

PhillyVoice.com8d ago

FDA Approves Merck's Daily Pill Lipfendra for Lowering LDL Cholesterol